{
  "actions": [
    {
      "acted_at": "2019-10-08", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-10-08", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-10-08", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-10-08", 
      "action_code": "", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-10-09", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4619-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "02"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "H001038", 
      "district": "26", 
      "name": "Higgins, Brian", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-10-08", 
      "state": "NY", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "W000826", 
      "district": "7", 
      "name": "Wild, Susan", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-10-08", 
      "state": "PA", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-10-08", 
  "number": "4619", 
  "official_title": "To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part D rebate for certain drugs if the price of such drugs increases faster than inflation.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr3-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Pharmaceutical Rebates for Excessive Pricing Above Inflation Act", 
  "sponsor": {
    "bioguide_id": "S001145", 
    "district": "9", 
    "name": "Schakowsky, Janice D.", 
    "state": "IL", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-10-08", 
  "subjects": [
    "Business records", 
    "Civil actions and liability", 
    "Government information and archives", 
    "Government trust funds", 
    "Health", 
    "Health care costs and insurance", 
    "Inflation and prices", 
    "Medicare", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2019-10-08T04:00:00Z", 
    "text": "Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act\n\nThis bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation."
  }, 
  "titles": [
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Pharmaceutical REPAI Act", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part D rebate for certain drugs if the price of such drugs increases faster than inflation.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Pharmaceutical Rebates for Excessive Pricing Above Inflation Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Pharmaceutical REPAI Act", 
      "type": "short"
    }
  ], 
  "updated_at": "2020-12-28T22:31:32Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4619.xml"
}